ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryMedical Technology IndustryEysinsBD Switzerland Sàrl
BD Switzerland Sàrl Logo
Verified· 2 sources

BD Switzerland Sàrl

Summary

About the company

BD Switzerland Sàrl is part of the BD group and provides molecular diagnostics products, instruments and assays. Offerings include automated platforms such as the BD MAX™ System and BD COR™ System, and assays for infectious diseases and cervical cancer testing.

AI-generated
Offering

Products & services

Industry:Medical Technology Industry
✓ Offered10
Molecular diagnostic systems (BD MAX™ System)
Automated molecular platform for nucleic acid extraction and real-time PCR, with results for up to 24 samples and a broad menu of assays.
Automated high-throughput molecular diagnostic systems (BD COR™ System)
Modular automated platform for a complete molecular workflow, with integrated pre-analytics, processing of multiple assays and high throughput for screening.
Cervical cancer screening portfolio
Analysis and instrument solutions for cytology, HPV screening, co-testing and preparation/imaging of cervical samples.
HPV test (BD Onclarity™ HPV Assay)
DNA PCR assay for detection of HPV with extended genotyping, internal cellularity control and option for self-collected vaginal samples.
Liquid-based Pap test (BD SurePath™ Liquid-based Pap Test)
Vial and liquid-based Pap test for cervical cytology, with single sample collection for cytology, HPV co-testing and reflex tests.
Cervical cytology instruments
Preparation, cell enrichment, slide preparation and staining, imaging and triage for cervical cytology and non-gynaecological samples.
Gastrointestinal infection screening portfolio
Targeted molecular panels for intestinal bacterial, viral and parasitic infections, with faster results and support for patient management.
Healthcare-associated infection screening portfolio
Molecular solutions for screening and active surveillance of HAI and MDRO, including CPO, ESBL, MRSA, Cdiff and vancomycin resistance.
Respiratory infection diagnostics portfolio
Molecular tests for SARS-CoV-2, influenza, RSV and drug-resistant tuberculosis for rapid detection of respiratory pathogens.
Women’s disease and STI screening portfolio
Molecular solutions for Chlamydia, gonorrhoea, Trichomonas, vaginosis/vaginitis and other screening and gynaecological diagnostic needs.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Comparisons

BD Switzerland Sàrl in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank BD Switzerland Sàrl by reviews, experience and specialisations.

Is this your company?

Claim the company profile of BD Switzerland Sàrl to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Route de Crassier 17
1262 Eysins

At a glance

Legal form
Limited Liability Company
UID
CHE-110.639.285
Founded
2004 · 22 years
Last commercial register change
September 8, 2026
Employees
21 to 50

Knowledge

No knowledge articles yet

Once BD Switzerland Sàrl has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

HD
Hedera Dx SA
Epalinges
MS
Med-Innova SA
Perroy
AN
Aleva Neurotherapeutics SA
Lausanne
BC
Beckman Coulter International SA
Nyon
CS
Comphya SA
Lausanne
RD
Rea Diagnostics SA
Lausanne
ME
Medtronic Europe Sàrl
Tolochenaz
MB
Medtronic BioPharma Sàrl
Tolochenaz